跳转至内容
Merck
CN

RNI00145

Sigma-Aldrich

(2S)-2-Phenyl-2,3-dihydroimidazo[2,1-b][1,3]benzothiazole

别名:

(S)-BTM

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C15H12N2S
分子量:
252.33
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:

表单

solid

SMILES字符串

C12=CC=CC=C1SC3=N[C@@H](C4=CC=CC=C4)CN23

InChI

1S/C15H12N2S/c1-2-6-11(7-3-1)12-10-17-13-8-4-5-9-14(13)18-15(17)16-12/h1-9,12H,10H2/t12-/m1/s1

InChI key

YGCWPCVAVSIFLO-GFCCVEGCSA-N

应用

Organocatalyst for the kinetic resolution of secondary alcohols by acylation with anhydrides.

Kinetic Resolution of Secondary Alcohols Using Amidine-Based Catalysts

其他说明

Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final.

NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.

相关产品

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Diastereoselective and Enantioselective Silylation of 2-Arylcyclohexanols
Wang L, et al.
Organic Letters, 17 (10), 2408?2411-2408?2411 (2015)

商品

作为我们不对称催化产品组合的一部分,我们很自豪地以(R)和(S)对映体形式提供异硫脲有机催化剂均苯并四咪唑(HBTM)。

We are proud to offer the isothiourea organocatalyst homobenzotetramisole (HBTM) as part of our asymmetric catalysis portfolio in both (R) and (S) enantiomeric forms.

相关内容

The main focus of research in the Birman group is on the de novo design of asymmetric catalysts and reagents. As part of this effort, they have developed Amidine-Based Catalysts, or ABCs, and demonstrated their high enantioselectivity in many asymmetric acyl transfer reactions. The versatility, accessibility, and ease of structural modification of ABCs have attracted the interest of a number of other research groups worldwide, which has led to further expansion of their synthetic utility.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门